Swiss - Delayed Quote CHF

DocMorris AG (DOCM.SW)

19.26
-0.98
(-4.84%)
At close: 5:31:16 PM GMT+2
Loading Chart for DOCM.SW
  • Previous Close 20.24
  • Open 19.86
  • Bid --
  • Ask --
  • Day's Range 18.95 - 20.00
  • 52 Week Range 14.90 - 76.85
  • Volume 245,244
  • Avg. Volume 139,514
  • Market Cap (intraday) 227.586M
  • Beta (5Y Monthly) 1.87
  • PE Ratio (TTM) --
  • EPS (TTM) -8.25
  • Earnings Date May 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 30.60

DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products. It also provides professional health care services. The company sells its products to online mail-order pharmacies, and private individuals under the PromoFarma by DocMorris, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.

corporate.docmorris.com/en

1,454

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DOCM.SW

View More

Performance Overview: DOCM.SW

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

DOCM.SW
3.60%
MSCI WORLD (^990100-USD-STRD)
0.22%

1-Year Return

DOCM.SW
74.32%
MSCI WORLD (^990100-USD-STRD)
9.28%

3-Year Return

DOCM.SW
83.94%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

DOCM.SW
87.69%
MSCI WORLD (^990100-USD-STRD)
79.97%

Compare To: DOCM.SW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DOCM.SW

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    239.17M

  • Enterprise Value

    456.00M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.23

  • Price/Book (mrq)

    0.70

  • Enterprise Value/Revenue

    0.45

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -9.56%

  • Return on Assets (ttm)

    -7.84%

  • Return on Equity (ttm)

    -25.24%

  • Revenue (ttm)

    1.02B

  • Net Income Avi to Common (ttm)

    -97.25M

  • Diluted EPS (ttm)

    -8.25

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    95.37M

  • Total Debt/Equity (mrq)

    91.79%

  • Levered Free Cash Flow (ttm)

    41.4M

Research Analysis: DOCM.SW

View More

Company Insights: DOCM.SW

Research Reports: DOCM.SW

View More

People Also Watch